These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Association of systemic lupus erythematosus and dermatopolymyositis]. Kilani B; Amari L; Houmane H; Ben Châabane T Tunis Med; 2005 Apr; 83(4):230-2. PubMed ID: 15966670 [TBL] [Abstract][Full Text] [Related]
23. Photosensitive psoriasis--an immunohistochemical study after light provocation with UVA and UVB. Ros AM; Wennersten G Photodermatol; 1987 Apr; 4(2):79-87. PubMed ID: 3309902 [TBL] [Abstract][Full Text] [Related]
24. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus. Arroyave CM; Wilson MR; Tan EM J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434 [TBL] [Abstract][Full Text] [Related]
26. Immunological changes following treatment of psoriasis with cyclosporin. Tigalonowa M; Bjerke JR; Gallati H; Matre R Acta Derm Venereol Suppl (Stockh); 1989; 146():142-5; discussion 146. PubMed ID: 2481929 [TBL] [Abstract][Full Text] [Related]
27. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748 [TBL] [Abstract][Full Text] [Related]
28. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818 [TBL] [Abstract][Full Text] [Related]
29. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [TBL] [Abstract][Full Text] [Related]
30. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans. Oxholm A APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657 [TBL] [Abstract][Full Text] [Related]
31. [Lupus erythematosus and hereditary lack of complement. Review of about one case of C2 deficit (author's transl)]. Morel P; Sohier J; Peltier AP; Cottenot F; Civatte J Ann Dermatol Venereol; 1977 Dec; 104(12):831-9. PubMed ID: 613949 [TBL] [Abstract][Full Text] [Related]
32. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258 [TBL] [Abstract][Full Text] [Related]
33. Histologic features of cutaneous lupus erythematosus. Baltaci M; Fritsch P Autoimmun Rev; 2009 May; 8(6):467-73. PubMed ID: 19162243 [TBL] [Abstract][Full Text] [Related]
34. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus. Gharavi AE; Elkon KB; Schifferli JA; Hughes GR J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885 [TBL] [Abstract][Full Text] [Related]
35. C3d,g is present in normal human epidermal basement membrane. Basset-Seguin N; Dersookian M; Cehrs K; Yancey KB J Immunol; 1988 Aug; 141(4):1273-80. PubMed ID: 3135326 [TBL] [Abstract][Full Text] [Related]
36. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test. Barnadas MA; Gilaberte M; Pujol R; Agustí M; Gelpí C; Alomar A Int J Dermatol; 2006 Sep; 45(9):1089-92. PubMed ID: 16961518 [TBL] [Abstract][Full Text] [Related]
37. The coexistence of rheumatoid arthritis and systemic lupus erythematosus: a case report and review of the literature. Fischman AS; Abeles M; Zanetti M; Weinstein A; Rothfield NF J Rheumatol; 1981; 8(3):405-15. PubMed ID: 7288757 [TBL] [Abstract][Full Text] [Related]
38. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus. Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422 [TBL] [Abstract][Full Text] [Related]